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Abstract 
Most reports investigating the hormonal and metabolic effects of bariatric surgery studied obese subjects after 
partial weight loss only. Nevertheless, all studies showed significant improvements of insulin secretion, action, 
clearance and inhibition of its own secretion, although the parallel kinetics of all these changes remained 
questionable. Using the intravenous glucose tolerance test, we demonstrated a full normalization of insulin 
secretion, action on glucose metabolism and clearance in eight obese women who recovered and maintained 
ideal body weight following gastroplasty. Reciprocal changes were observed between postglucose acute insulin 
secretion and insulin-mediated glucose disposal so that the so-called disposition index (product of these two 
variables) remained unchanged after vs before gastroplasty in those individuals with normal glucose tolerance. 
These favourable results should encourage obtaining a drastic and sustained weight loss in patients with severe 
obesity at risk of developing type II diabetes. 
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Obesity is rapidly growing in all countries, especially its massive form in the United States.1 Numerous 
epidemiological1 and clinical studies2 have demonstrated that obesity is strongly and causally linked to impaired 
glucose metabolism and type II diabetes. Weight management has the potential to make a significant impact in 
subjects with established type II diabetes, and recent data suggest that prevention of diabetes is feasible if weight 
management is addressed adequately in individuals at high risk.3 Hyperinsulinaemia is a key feature of obese 
subjects. Such high circulating insulin levels may result from various mechanisms, that is, increased insulin 
secretion (at least partially as a compensatory mechanism in face of insulin resistance) and decreased insulin 
clearance (presumably due to a reduced hepatic insulin extraction).4 Pereira et al5 recently reported in the Journal 
that insulin inhibition on its own secretion was blunted in insulin-resistant severely obese patients, partially 
related to the degree of obesity, a phenomenon that may contribute to aggravate hyperinsulinaemia. In addition, 
they demonstrated that postsurgery (either vertical banded gastroplasty or gastric bypass) weight loss completely 
normalized the insulin effect on its own secretion, despite the persistence of moderate obesity, while it only 
partially improved insulin-induced glucose uptake. 
In a previous study, Pereira et al5 showed that insulin infusion under euglycaemic conditions at steady state 
inhibits its own secretion in lean subjects but that this insulin action is blunted in the obese group.6 By contrast, 
our group reported a normal feedback inhibition of insulin secretion by insulin in moderately obese subjects, 
contrasting with a markedly reduced metabolic clearance rate of the hormone, a factor that may contribute to 
hyperinsulinaemia.7 However, obese subjects evaluated by our group had a less extreme obesity as compared to 
those tested by Pereira et al (BMI: 33.0 vs 54.6 kg/m2), a difference that may suggest that blunted inhibition of 
insulin on its own secretion is only present in morbidly obese subjects. A further argument in favour of such a 
conclusion is the observation of Pereira et al5 that the insulin inhibitory effect on its secretion is fully restored 
after partial weight loss despite the persistence of elevated body weight. Apparently, the improvement of this 
inhibitory effect of insulin on its own secretion after gastroplasty or gastric bypass was not clearly related to the 
degree of weight loss as it appeared more pronounced at 4 months (when BMI decreased from 54.6 to 44.5 
kg/m2) than at 14 months (when BMI further decreased to 33.9 kg/m2). The results of Pereira et al5 suggested a 
partial dissociation between an apparently full normalization of insulin inhibition on insulin secretion (no more 
insulin resistance at the B-cell level, a mechanism that may contribute to modulate insulin secretion) and a 
persistent decrease in insulin-mediated glucose disposal (still insulin resistance at the muscle site) after weight 
reduction. A dissociation between changes in insulin secretion and insulin sensitivity has already been reported 
during the course of drastic weight loss after bariatric surgery with, however, a restoration of insulin sensitivity 
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preceding that of insulin secretion.8 In a previous study, we reported partial but comparable postweight loss 
improvement of insulin secretion and insulin sensitivity in 12 severely obese subjects who still remained 
overweight after bariatric surgery (BMI reduction from 37.9 to 26.5 kg/m2).9
None of these studies investigated these hormonal and metabolic parameters in individuals who recovered ideal 
body weight. Fortunately, we had the opportunity to evaluate eight obese women after recovery and stabilization 
of ideal body weight 14 months after a successful vertical banded gastroplasty (reduction of BMI from 37.7 to 
23.7 kg/ m2).10 In those subjects, we demonstrated a full normalization of insulin secretion, action on glucose 
metabolism and clearance. These results were obtained during a frequently sampled intravenous glucose 
tolerance test using the minimal model approach to assess insulin sensitivity and the deconvolution of plasma         
C-peptide levels to assess insulin secretion kinetics. This technique does not allow studying the insulin inhibition 
on insulin secretion and thus we cannot compare our data with those of Pereira et al5 in this respect. However, 
the intravenous glucose tolerance test allows a careful evaluation of the intimate relationship between acute 
insulin response (AIR) to glucose and insulin sensitivity as previously described.11 The importance of the so-
called disposition index (AIR x insulin sensitivity) has been recently emphasized and illustrated in various 
clinical conditions.12,13 Figure 1 illustrates the reciprocal changes in AIR and insulin sensitivity index after vs 
before weight loss in the above-mentioned eight obese women with normal glucose tolerance who succeeded in 
normalizing BMI after gastroplasty14 The cross-talk between insulin secretion and insulin sensitivity is illustrated 
by the rightward and downward shift of the dots from 'before gastroplasty' to 'after gastroplasty' along the 
hyperbolic curve linking AIR and insulin sensitivity observed in a large cohort of 109 subjects with variable 
BMI but normal glucose tolerance during an oral glucose tolerance test. Thus, the disposition index remained 
almost unchanged in postobese subjects evaluated after gastroplasty as compared to the values calculated before 
gastroplasty when severe obesity was present (45433 ± 9284 vs 36407 ± 6369 10-5 l.min-1, P = 0.387, NS). 
However, fasting and postload glucose concentrations were slightly increased in severely obese subjects with 
decreasing insulin sensitivity despite normal compensation of AIR, as compared to lean and postobese subjects.10 
Changes along the hyperbola, with disposition index remaining constant, are consistent with the hypothesis that 
glucose is a signal that stimulates AIR to compensate for insulin resistance, a concept recently called 'glucose 
allostasis'.13
 
Figure 1: Hyperbolic relationship between acute insulin response to glucose (AIRGO-10min) and insulin sensitivity 
(SI) measured during a frequently sampled intravenous glucose tolerance test. The curve was derived from the 
results obtained in a personal series of 109 subjects with variable BMI but normal glucose tolerance. Changes 
after (postobese) vs before (obese) gastroplasty are illustrated in eight obese women who recovered ideal body 
weight after bariatric surgery (mean  ±  s.e.m.). 
 
 
In conclusion, postgastroplasty recovery of ideal body weight in severely obese subjects results in a full 
normalization of all indices of insulin secretion, action and clearance, the so-called 'disposition index' remaining 
constant. Such results represent a further argument for obtaining and maintaining a drastic weight loss in patients 
with extreme obesity at high risk of developing type II diabetes. They may explain why the incidence of type II 
diabetes is drastically decreased in obese patients submitted to bariatric surgery as demonstrated after 2 and 8 
years of follow-up in the prospective Swedish Obese Subjects study15
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